| Authors: |
Siva J; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Wong A; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Lewis K; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Munoz-Lopez C; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Maina EN; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Rathi N; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Kazama A; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.; Division of Molecular Oncology, Department of Urology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan., Bartholomew A; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Heller N; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Scovell JM; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Campbell RA; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Almassi N; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Abouassaly R; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Haywood SC; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Weight CJ; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Campbell SC; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. |
